US3926723A
(en)
|
1974-08-08 |
1975-12-16 |
Massachusetts Inst Technology |
Method of controllably releasing glucose to a cell culture medium
|
US4657863A
(en)
*
|
1982-07-02 |
1987-04-14 |
Celanese Corporation |
Stabilization of a mutant microorganism population
|
JPS63502716A
(ja)
|
1986-03-07 |
1988-10-13 |
マサチューセッツ・インステチュート・オブ・テクノロジー |
糖タンパク安定性の強化方法
|
JPS62258252A
(ja)
|
1986-04-30 |
1987-11-10 |
Koyo Seiko Co Ltd |
ベルト用オ−トテンシヨナ
|
JPH066054B2
(ja)
|
1987-10-15 |
1994-01-26 |
帝人株式会社 |
動物細胞の培養方法
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
US6238891B1
(en)
|
1987-11-18 |
2001-05-29 |
Cetus Oncology Corporation |
Method of increasing product expression through solute stress
|
CA1312030C
(en)
|
1987-11-18 |
1992-12-29 |
Brian Maiorella |
Method to increase antibody titer
|
US5670373A
(en)
|
1988-01-22 |
1997-09-23 |
Kishimoto; Tadamitsu |
Antibody to human interleukin-6 receptor
|
US6428979B1
(en)
|
1988-01-22 |
2002-08-06 |
Tadamitsu Kishimoto |
Receptor protein for human B cell stimulatory factor-2
|
US5171840A
(en)
|
1988-01-22 |
1992-12-15 |
Tadamitsu Kishimoto |
Receptor protein for human B cell stimulatory factor-2
|
KR0132666B1
(en)
|
1989-03-14 |
1998-04-14 |
Hitachi Kk |
Method for controlling cultivation conditions for animal cells
|
DE69029015T2
(de)
|
1989-07-20 |
1998-01-22 |
Tadamitsu Kishimoto |
Antikörper gegen menschlichen Interleukin-6-Rezeptor
|
HUT60768A
(en)
|
1990-03-16 |
1992-10-28 |
Sandoz Ag |
Process for producing cd25 fixing molecules
|
EP0527760B1
(en)
|
1990-04-03 |
1995-07-19 |
Genentech, Inc. |
Methods and compositions for vaccination against hiv
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
GB9022545D0
(en)
*
|
1990-10-17 |
1990-11-28 |
Wellcome Found |
Culture medium
|
DE4037325A1
(de)
|
1990-11-23 |
1992-05-27 |
Karl Mueller U Co Kg |
Verfahren zur erzeugung von zellmasse und/oder fermentierungsprodukten unter sterilen bedingungen sowie vorrichtung zur durchfuehrung des verfahrens
|
KR100249937B1
(ko)
|
1991-04-25 |
2000-04-01 |
나가야마 오사무 |
인간 인터루킨-6 수용체에 대한 재구성 인간 항체
|
JPH05227970A
(ja)
|
1992-02-19 |
1993-09-07 |
Chugai Pharmaceut Co Ltd |
ヒトインターロイキン−6受容体に対する再構成ヒト抗体
|
US5821121A
(en)
|
1991-06-24 |
1998-10-13 |
Pacific Biomedical Research, Inc. |
Hormone-secreting cells maintained in long-term culture
|
EP0605428B9
(en)
|
1991-06-24 |
2003-01-02 |
hCell Technology, Inc. |
Hormone-secreting pancreatic cells maintained in long-term culture
|
US5610297A
(en)
|
1991-12-27 |
1997-03-11 |
Georgia Tech Research Corp. |
Peptides ketoamides
|
US5252216A
(en)
*
|
1992-03-24 |
1993-10-12 |
Smithkline Beecham Corporation |
Protein purification
|
EP0567738A3
(en)
|
1992-05-01 |
1995-09-06 |
American Cyanamid Co |
Controlling perfusion rates in continuous bioreactor culture of animal cells
|
US5443968A
(en)
|
1992-05-01 |
1995-08-22 |
Teijin Limited |
Fed batch culture method for protein secreting cells
|
ES2091684T3
(es)
|
1992-11-13 |
1996-11-01 |
Idec Pharma Corp |
Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
|
JPH06292592A
(ja)
*
|
1993-02-09 |
1994-10-21 |
Snow Brand Milk Prod Co Ltd |
糖蛋白質の生産方法
|
WO1994026087A2
(en)
|
1993-05-14 |
1994-11-24 |
Connor Kim C O |
Recombinant protein production and insect cell culture and process
|
US5888510A
(en)
|
1993-07-21 |
1999-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
USH1532H
(en)
|
1993-11-03 |
1996-05-07 |
Genetics Institute, Inc. |
Adaption of mammalian cell lines to high cell densities
|
DE69408541T2
(de)
|
1993-11-23 |
1998-08-06 |
Genentech Inc |
Kinaserezeptoraktivierungstest
|
US20030108545A1
(en)
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
JP3083324B2
(ja)
|
1994-02-18 |
2000-09-04 |
帝人株式会社 |
動物細胞の培養方法
|
US5856179A
(en)
|
1994-03-10 |
1999-01-05 |
Genentech, Inc. |
Polypeptide production in animal cell culture
|
ES2162917T3
(es)
|
1994-05-13 |
2002-01-16 |
Biovation Ltd |
Mejoras en o relativas al suministro de peptidos.
|
US8017121B2
(en)
*
|
1994-06-30 |
2011-09-13 |
Chugai Seiyaku Kabushika Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
JP3630453B2
(ja)
|
1994-09-30 |
2005-03-16 |
中外製薬株式会社 |
Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
|
CN101011574B
(zh)
|
1994-10-21 |
2012-10-03 |
岸本忠三 |
Il-6受体的抗体在制备药物组合物中的用途
|
WO1996020728A1
(fr)
|
1994-12-29 |
1996-07-11 |
Chugai Seiyaku Kabushiki Kaisha |
Potentialisateur d'agent antitumoral comprenant un antagoniste de l'interleukine 6
|
WO1996025174A1
(fr)
|
1995-02-13 |
1996-08-22 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibiteur de decomposition des proteines musculaires contenant un anticorps du recepteur de l'interleukine-6
|
GB9506249D0
(en)
*
|
1995-03-27 |
1995-05-17 |
Karobio Ab |
Media for insect cell cultures
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
JP3596108B2
(ja)
|
1995-08-30 |
2004-12-02 |
株式会社デンソー |
車両用空調装置
|
US6087129A
(en)
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
US6692742B1
(en)
|
1996-06-27 |
2004-02-17 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for myeloma to be used together with nitrogen mustard antitumor agents
|
US7147851B1
(en)
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
WO1998041611A1
(en)
|
1997-03-20 |
1998-09-24 |
Regents Of The University Of Minnesota |
Process for the continuous culture of cells
|
ES2382488T3
(es)
|
1997-03-21 |
2012-06-08 |
Chugai Seiyaku Kabushiki Kaisha |
Un agente preventivo o terapéutico para enfermedades mediadas por células t sensibilizadas que comprende un antagonista de il-6 como ingrediente activo
|
JP3707583B2
(ja)
|
1997-06-06 |
2005-10-19 |
株式会社ブリヂストン |
金属線用ガイド
|
US20020187150A1
(en)
|
1997-08-15 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
|
RU2195960C2
(ru)
|
1998-03-17 |
2003-01-10 |
Тугаи Сейяку Кабусики Кайся |
Профилактический или терапевтический агент для лечения воспалительных заболеваний кишечника, содержащий в качестве активного ингредиента антагонист il-6
|
PT1068241E
(pt)
|
1998-04-02 |
2007-11-19 |
Genentech Inc |
Variantes de anticorpos e respectivos fragmentos
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
US6537782B1
(en)
|
1998-06-01 |
2003-03-25 |
Chugai Seiyaku Kabushiki Kaisha |
Media for culturing animal cells and process for producing protein by using the same
|
US6406909B1
(en)
*
|
1998-07-10 |
2002-06-18 |
Chugai Seiyaku Kabushiki Kaisha |
Serum-free medium for culturing animal cells
|
ES2276525T3
(es)
|
1998-08-24 |
2007-06-16 |
Chugai Seiyaku Kabushiki Kaisha |
Preventivos o remedios para la pancreatitis que contienen anticuerpos anti-receptor il-6 como ingrediente activo.
|
ES2420835T3
(es)
|
1999-04-09 |
2013-08-27 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento para controlar la actividad de las moléculas inmunofuncionales
|
DK1178999T3
(da)
|
1999-05-04 |
2007-08-06 |
Santaris Pharma As |
L-RIBO-LNA-analoger
|
US6338964B1
(en)
|
1999-05-07 |
2002-01-15 |
Bayer Corporation |
Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
US6284453B1
(en)
|
1999-09-29 |
2001-09-04 |
Steven Anthony Siano |
Method for controlling fermentation growth and metabolism
|
JP2001101882A
(ja)
|
1999-09-29 |
2001-04-13 |
Sony Corp |
不揮発性半導体記憶装置
|
AU5901501A
(en)
|
1999-10-19 |
2001-10-23 |
Nicholas R. Abu-Absi |
Measurement of nutrient uptake in cells and methods based thereon
|
GB0001448D0
(en)
|
2000-01-21 |
2000-03-08 |
Novartis Ag |
Organic compounds
|
AU2001263769A1
(en)
|
2000-05-30 |
2001-12-11 |
Lactascan Aps |
Method for producing lactic acid
|
US20030165502A1
(en)
|
2000-06-13 |
2003-09-04 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
AU2001271021A1
(en)
|
2000-07-05 |
2002-01-14 |
Japan As Represented By Secretary Of Osaka University |
Process for producing glycoprotein
|
AU2001278716A1
(en)
|
2000-08-10 |
2002-02-25 |
Chugai Seiyaku Kabushiki Kaisha |
Method of inhibiting antibody-containing solution from coagulating or becoming turbid
|
WO2002013860A1
(fr)
*
|
2000-08-11 |
2002-02-21 |
Chugai Seiyaku Kabushiki Kaisha |
Preparations stabilisees contenant un anticorps
|
GB0020685D0
(en)
|
2000-08-22 |
2000-10-11 |
Novartis Ag |
Organic compounds
|
WO2002030954A1
(fr)
|
2000-10-06 |
2002-04-18 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de purification d'un anticorps
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
DE60139944D1
(de)
*
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
CN1308447C
(zh)
|
2000-10-20 |
2007-04-04 |
中外制药株式会社 |
低分子化的激动剂抗体
|
NZ525394A
(en)
|
2000-10-20 |
2005-12-23 |
Bioneer As |
Improved fermentation method for production of heterologous gene products in lactic acid bacteria
|
US7320792B2
(en)
*
|
2000-10-25 |
2008-01-22 |
Chugai Seiyaku Kabushiki Kaisha |
Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist
|
WO2002036164A1
(fr)
*
|
2000-10-27 |
2002-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Agent abaissant le taux sanguin de vegf contenant un antagoniste de il-6 en tant que principe actif
|
AU2000279625A1
(en)
|
2000-10-27 |
2002-05-15 |
Chugai Seiyaku Kabushiki Kaisha |
Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
|
DK1332222T3
(da)
|
2000-11-03 |
2009-07-06 |
Genentech Inc |
Stofskifteændringer i fermenteringer der udtrykker rekombinante proteiner
|
BR0115558A
(pt)
|
2000-11-22 |
2004-08-17 |
Cargill Dow Polymers Llc |
ácido nucleico isolado, construção de expressão recombinante, célula de levedura transformada com a construção de expressão recombinante, e, método para produzir ácido lático
|
AR032028A1
(es)
|
2001-01-05 |
2003-10-22 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina
|
CZ20031886A3
(cs)
|
2001-01-19 |
2003-10-15 |
Basf Aktiengesellschaft |
Způsob přípravy pantothenátu ve vyšším výtěžku a mikroorganizmy používané při tomto způsobu
|
US7332289B2
(en)
|
2001-03-09 |
2008-02-19 |
Chugai Seiyaku Kabushiki Kaisha |
Method of purifying protein
|
JP2005509403A
(ja)
|
2001-03-27 |
2005-04-14 |
スミスクライン・ビーチャム・コーポレイション |
IgGにおけるグリコフォームの制御
|
UA80091C2
(en)
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
JP4236934B2
(ja)
|
2001-04-17 |
2009-03-11 |
中外製薬株式会社 |
界面活性剤の定量方法
|
KR20020088848A
(ko)
|
2001-05-21 |
2002-11-29 |
(주)코아바이오텍 |
세포배양관 및 이를 이용한 대량 세포배양기
|
WO2002101019A2
(en)
|
2001-06-13 |
2002-12-19 |
Genentech, Inc. |
Methods of culturing animal cells and polypeptide production in animal cells
|
IL159856A0
(en)
|
2001-07-23 |
2004-06-20 |
Zymogenetics Inc |
Fermentation medium and method
|
PT1461359E
(pt)
|
2002-01-18 |
2007-06-29 |
Pf Medicament |
Anticorpos anti-igf-ir e suas aplicações
|
US7553485B2
(en)
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
CA2475406C
(en)
|
2002-02-08 |
2011-11-15 |
Genencor International, Inc. |
Methods for producing end-products from carbon substrates
|
EP3192528A1
(en)
|
2002-02-14 |
2017-07-19 |
Chugai Seiyaku Kabushiki Kaisha |
Formulation of anti-il6r antibody-containing solutions comprising a sugar as a stabilizer
|
CA2417689C
(en)
|
2002-03-05 |
2006-05-09 |
F. Hoffmann-La Roche Ag |
Improved methods for growing mammalian cells in vitro
|
JP3958089B2
(ja)
|
2002-03-26 |
2007-08-15 |
有限会社新世紀発酵研究所 |
嫌気性菌の連続培養法
|
JP3822137B2
(ja)
|
2002-05-20 |
2006-09-13 |
中外製薬株式会社 |
動物細胞培養用培地の添加剤およびそれを用いたタンパク質の製造方法
|
EP2316922B1
(en)
|
2002-05-24 |
2013-05-22 |
Merck Sharp & Dohme Corp. |
Neutralizing human anti-IGFR antibody
|
US8142810B2
(en)
|
2002-05-30 |
2012-03-27 |
The Procter & Gamble Company |
Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
CN1788089A
(zh)
|
2002-07-03 |
2006-06-14 |
巴斯福股份公司 |
用于提高泛酸产量的微生物和方法
|
AU2002316575A1
(en)
|
2002-07-03 |
2004-01-23 |
Basf Aktiengesellschaft |
Microorganisms and processes for enhanced production of pantothenate
|
CN1470632A
(zh)
|
2002-07-25 |
2004-01-28 |
谢良志 |
一种动物细胞的优化流加悬浮培养方法
|
SI1561756T1
(sl)
*
|
2002-09-11 |
2016-02-29 |
Chugai Seiyaku Kabushiki Kaisha |
Postopek čiščenja proteinov
|
US20040209930A1
(en)
|
2002-10-02 |
2004-10-21 |
Carboni Joan M. |
Synergistic methods and compositions for treating cancer
|
US7550262B2
(en)
|
2002-11-05 |
2009-06-23 |
Mount Sinai School Of Medicine Of New York University |
PTPN11 (SHP-2) mutations and cancer
|
DE10255508A1
(de)
|
2002-11-27 |
2004-06-17 |
Forschungszentrum Jülich GmbH |
Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
|
PL222222B1
(pl)
|
2003-01-22 |
2016-07-29 |
Glycart Biotechnology Ag |
Sposób wytwarzania polipeptydu
|
NZ582210A
(en)
|
2003-02-13 |
2011-04-29 |
Pfizer Prod Inc |
Uses of anti-insulin-like growth factor I receptor antibodies
|
PL378199A1
(pl)
|
2003-02-24 |
2006-03-06 |
Chugai Seiyaku Kabushiki Kaisha |
Środek terapeutyczny do stosowania w urazach rdzenia kręgowego, zawierający antagonistę interleukiny-6
|
EP1603948A1
(en)
|
2003-03-14 |
2005-12-14 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
US7378503B2
(en)
|
2003-04-02 |
2008-05-27 |
Hoffmann-La Roche Inc. |
Antibodies against insulin-like growth factor 1 receptor and uses thereof
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
WO2005016970A2
(en)
|
2003-05-01 |
2005-02-24 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
PT1623019E
(pt)
*
|
2003-05-15 |
2010-07-20 |
Wyeth Llc |
ALIMENTAÃO COM GLUCOSE DE MODO LIMITADO PARA CULTURA DE CéLULAS ANIMAIS
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
MXPA06001634A
(es)
|
2003-08-13 |
2006-04-28 |
Pfizer Prod Inc |
Anticuerpos humanos modificados igf-1r.
|
GB0321100D0
(en)
|
2003-09-09 |
2003-10-08 |
Celltech R&D Ltd |
Biological products
|
AR045614A1
(es)
|
2003-09-10 |
2005-11-02 |
Hoffmann La Roche |
Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos
|
ES2392824T3
(es)
|
2003-10-17 |
2012-12-14 |
Chugai Seiyaku Kabushiki Kaisha |
Agente terapéutico contra el mesotelioma
|
FR2861080B1
(fr)
|
2003-10-20 |
2006-02-17 |
Lab Francais Du Fractionnement |
Anticorps presentant un taux de fucose et de galactose optimise
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
AR048210A1
(es)
|
2003-12-19 |
2006-04-12 |
Chugai Pharmaceutical Co Ltd |
Un agente preventivo para la vasculitis.
|
US8617550B2
(en)
|
2003-12-19 |
2013-12-31 |
Chugai Seiyaku Kabushiki Kaisha |
Treatment of vasculitis with IL-6 antagonist
|
EP1737493B1
(en)
|
2004-02-25 |
2011-06-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumor cell growth
|
AR048335A1
(es)
*
|
2004-03-24 |
2006-04-19 |
Chugai Pharmaceutical Co Ltd |
Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
|
EP3269738A1
(en)
|
2004-03-24 |
2018-01-17 |
Chugai Seiyaku Kabushiki Kaisha |
Subtypes of humanized antibody against interleukin-6 receptor
|
US20060002930A1
(en)
|
2004-04-16 |
2006-01-05 |
Genentech, Inc. |
Treatment of disorders
|
WO2006008639A1
(en)
|
2004-07-16 |
2006-01-26 |
Pfizer Products Inc. |
Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
US7432359B2
(en)
|
2004-09-06 |
2008-10-07 |
Kirin Pharma Kabushiki Kaisha |
Anti-A33 antibody
|
WO2006073070A1
(ja)
|
2005-01-05 |
2006-07-13 |
Chugai Seiyaku Kabushiki Kaisha |
細胞の培養方法およびその利用
|
AU2006300234B2
(en)
*
|
2005-10-14 |
2013-01-10 |
Chugai Seiyaku Kabushiki Kaisha |
Agents for suppressing damage to transplanted islets after islet transplantation
|
CN101330930B
(zh)
|
2005-10-21 |
2011-11-23 |
中外制药株式会社 |
心脏病治疗剂
|
WO2007048077A2
(en)
|
2005-10-21 |
2007-04-26 |
Gtc Biotherapeutics, Inc. |
Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
|
AR057582A1
(es)
|
2005-11-15 |
2007-12-05 |
Nat Hospital Organization |
Agentes para suprimir la induccion de linfocitos t citotoxicos
|
JP2009515552A
(ja)
|
2005-11-17 |
2009-04-16 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
α4β7インテグリン反応性ヒト化免疫グロブリン
|
WO2007061029A1
(ja)
|
2005-11-25 |
2007-05-31 |
Keio University |
前立腺癌治療剤
|
EP1977763A4
(en)
|
2005-12-28 |
2010-06-02 |
Chugai Pharmaceutical Co Ltd |
STABILIZER PREPARATION CONTAINING ANTIBODIES
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
AR059213A1
(es)
|
2006-01-27 |
2008-03-19 |
Univ Keio |
Agentes terapeuticos para enfermedades que involucran neovascularizacion coroidal
|
KR101047207B1
(ko)
|
2006-03-09 |
2011-07-06 |
에프. 호프만-라 로슈 아게 |
항-약물 항체 분석
|
BRPI0709843A2
(pt)
|
2006-03-28 |
2011-07-26 |
Biogen Idec Inc |
anticorpos de anti-igf-1r e usos dos mesmos
|
WO2007116962A1
(ja)
|
2006-04-07 |
2007-10-18 |
Osaka University |
筋再生促進剤
|
US7846724B2
(en)
*
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
US20080014203A1
(en)
|
2006-04-11 |
2008-01-17 |
Silke Hansen |
Antibodies against insulin-like growth factor I receptor and uses thereof
|
WO2007143168A2
(en)
*
|
2006-06-02 |
2007-12-13 |
Regeneron Pharmaceuticals, Inc. |
High affinity antibodies to human il-6 receptor
|
JP5330829B2
(ja)
|
2006-08-04 |
2013-10-30 |
憲弘 西本 |
関節リウマチ患者の治療予後予測方法
|
WO2008036600A2
(en)
|
2006-09-18 |
2008-03-27 |
Genentech, Inc. |
Methods of protein production
|
JP4355743B2
(ja)
*
|
2006-12-04 |
2009-11-04 |
株式会社神戸製鋼所 |
Cu合金配線膜とそのCu合金配線膜を用いたフラットパネルディスプレイ用TFT素子、及びそのCu合金配線膜を作製するためのCu合金スパッタリングターゲット
|
JP2010095445A
(ja)
|
2006-12-27 |
2010-04-30 |
Tokyo Medical & Dental Univ |
Il−6アンタゴニストを有効成分とする炎症性筋疾患治療剤
|
WO2008090901A1
(ja)
|
2007-01-23 |
2008-07-31 |
Shinshu University |
慢性拒絶反応抑制剤
|
KR101615715B1
(ko)
*
|
2007-05-21 |
2016-04-27 |
앨더바이오 홀딩스 엘엘씨 |
Il-6에 대한 항체 및 이의 용도
|
US20100129355A1
(en)
|
2007-07-26 |
2010-05-27 |
Osaka University |
Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
|
MY162534A
(en)
|
2007-09-26 |
2017-06-15 |
Chugai Pharmaceutical Co Ltd |
Anti-il-6 receptor antibody
|
BRPI0817482B8
(pt)
|
2007-10-02 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
uso de um anticorpo do receptor da interleucina-6 (il-6) no tratamento da doença do enxerto versus hospedeiro (gvhd)
|
JP2009092508A
(ja)
|
2007-10-09 |
2009-04-30 |
Norihiro Nishimoto |
リウマチ治療剤の効果の予測方法
|
CN101802192A
(zh)
|
2007-10-15 |
2010-08-11 |
中外制药株式会社 |
抗体的制备方法
|
GB2453939A
(en)
|
2007-10-22 |
2009-04-29 |
Ubidyne Inc |
Clockless analogue band-pass delta-sigma modulator
|
EP2223118B1
(en)
|
2007-12-15 |
2013-02-27 |
F. Hoffmann-La Roche AG |
Distinguishing assay
|
PE20091174A1
(es)
|
2007-12-27 |
2009-08-03 |
Chugai Pharmaceutical Co Ltd |
Formulacion liquida con contenido de alta concentracion de anticuerpo
|
AU2009223054A1
(en)
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced ADCC function
|
DE102008013899A1
(de)
*
|
2008-03-12 |
2009-09-17 |
F. Hoffmann-La Roche Ag |
Verfahren zur Herstellung rekombinanter Proteine bei konstantem Gehalt von pCO2 im Medium
|
CN102256623A
(zh)
*
|
2008-06-05 |
2011-11-23 |
独立行政法人国立癌症研究中心 |
神经浸润抑制剂
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
TWI523661B
(zh)
|
2009-07-31 |
2016-03-01 |
Shin Maeda |
Anti-IL-6 receptor antibody in the manufacture of inhibitors of metastatic inhibition of lung cancer metastasis to the liver
|
WO2011019622A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Genentech, Inc. |
Cell culture methods to make antibodies with enhanced adcc function
|
KR102071834B1
(ko)
|
2009-10-26 |
2020-01-30 |
에프. 호프만-라 로슈 아게 |
글리코실화된 면역글로불린의 제조 방법
|
TWI609698B
(zh)
|
2010-01-20 |
2018-01-01 |
Chugai Pharmaceutical Co Ltd |
穩定化的含抗體溶液製劑
|
WO2011128096A1
(en)
*
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
JP6051049B2
(ja)
|
2010-05-28 |
2016-12-21 |
中外製薬株式会社 |
抗腫瘍t細胞応答増強剤
|
JP5904552B2
(ja)
|
2010-05-28 |
2016-04-13 |
国立研究開発法人国立がん研究センター |
膵癌治療剤
|
JP2013529089A
(ja)
*
|
2010-06-07 |
2013-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
インターロイキン−6受容体を阻害するモノクローナル抗体による薬剤治療に対する応答を予測するための遺伝子発現マーカー
|
BR112013007237A2
(pt)
|
2010-11-05 |
2016-06-14 |
Hoffmann La Roche |
''método para produzir um anticorpo anti-ig-1r''
|
KR20190120439A
(ko)
|
2010-11-08 |
2019-10-23 |
제넨테크, 인크. |
피하 투여용 항―il―6 수용체 항체
|
EP2750784A1
(en)
|
2011-09-01 |
2014-07-09 |
Chugai Seiyaku Kabushiki Kaisha |
Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
|
EP3800204A1
(en)
|
2013-04-16 |
2021-04-07 |
F. Hoffmann-La Roche AG |
Pertuzumab variants and evaluation thereof
|
WO2015000865A1
(en)
|
2013-07-04 |
2015-01-08 |
F. Hoffmann-La Roche Ag |
Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
|
AU2016224409B2
(en)
|
2015-02-27 |
2021-01-28 |
Chugai Seiyaku Kabushiki Kaisha |
Composition for treating IL-6-related diseases
|
AR104050A1
(es)
|
2015-03-26 |
2017-06-21 |
Chugai Pharmaceutical Co Ltd |
Proceso de producción con iones de cobre controlados
|